BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 14584940)

  • 1. Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.
    Rosini M; Antonello A; Cavalli A; Bolognesi ML; Minarini A; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 2003 Nov; 46(23):4895-903. PubMed ID: 14584940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
    Brasili L; Sorbi C; Franchini S; Manicardi M; Angeli P; Marucci G; Leonardi A; Poggesi E
    J Med Chem; 2003 Apr; 46(8):1504-11. PubMed ID: 12672251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Gentili F; Marucci G; Carrieri A; Carotti A; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 2002 Apr; 45(8):1633-43. PubMed ID: 11931617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
    Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.
    Sagratini G; Angeli P; Buccioni M; Gulini U; Marucci G; Melchiorre C; Leonardi A; Poggesi E; Giardinà D
    Bioorg Med Chem; 2007 Mar; 15(6):2334-45. PubMed ID: 17276073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.
    Konkel MJ; Wetzel JM; Cahir M; Craig DA; Noble SA; Gluchowski C
    J Med Chem; 2005 Apr; 48(8):3076-9. PubMed ID: 15828846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity.
    Quaglia W; Giannella M; Marucci G; Piergentili A; Pigini M; Tayebati SK; Melchiorre C
    Farmaco; 1996 Jan; 51(1):27-32. PubMed ID: 8721758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.
    Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Leonardi A; Taddei C; Melchiorre C
    J Med Chem; 1996 May; 39(11):2253-8. PubMed ID: 8667368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha1-adrenoceptor antagonists. 6. Structural optimization of pyridazinone-arylpiperazines. Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety.
    Betti L; Corelli F; Floridi M; Giannaccini G; Maccari L; Manetti F; Strappaghetti G; Botta M
    J Med Chem; 2003 Jul; 46(16):3555-8. PubMed ID: 12877594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
    Ivorra MD; Valiente M; Martínez S; Madrero Y; Noguera MA; Cassels BK; Sobarzo EM; D'Ocon P
    Planta Med; 2005 Oct; 71(10):897-903. PubMed ID: 16254819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
    Zhao MM; Hwa J; Perez DM
    Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
    Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
    J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of alpha 1 antagonist WB-4101.
    Bolchi C; Catalano P; Fumagalli L; Gobbi M; Pallavicini M; Pedretti A; Villa L; Vistoli G; Valoti E
    Bioorg Med Chem; 2004 Sep; 12(18):4937-51. PubMed ID: 15336273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
    Romeo G; Materia L; Manetti F; Cagnotto A; Mennini T; Nicoletti F; Botta M; Russo F; Minneman KP
    J Med Chem; 2003 Jul; 46(14):2877-94. PubMed ID: 12825930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogues of prazosin that bear a benextramine-related polyamine backbone exhibit different antagonism toward alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Marucci G; Angeli P; Buccioni M; Minarini A; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 2001 Feb; 44(3):362-71. PubMed ID: 11462977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton.
    Barlocco D; Cignarella G; Montesano F; Leonardi A; Mella M; Toma L
    J Med Chem; 1999 Jan; 42(1):173-7. PubMed ID: 9888842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.